Regulation of endothelial nitric oxide synthase activity by protein-protein interaction

Current Pharmaceutical Design

Volumn 20, Issue 22, 2014, Pages 3514-3520

  Su, Yunchao ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Endothelium; Nitric oxide; Protein interactions

Indexed keywords

AMINO ACID TRANSPORTER; APOLIPOPROTEIN A1; ARGININE; ARGININOSUCCINATE LYASE; ARGININOSUCCINATE SYNTHASE; BETA ACTIN; CALMODULIN; CAVEOLIN; CELL PROTEIN; CYTOSKELETON PROTEIN; DYNAMIN II; ENDOTHELIAL NITRIC OXIDE SYNTHASE; G PROTEIN COUPLED RECEPTOR; GUANYLATE CYCLASE; HEAT SHOCK PROTEIN 90; HIGH DENSITY LIPOPROTEIN; NITRIC OXIDE SYNTHASE INTERACTING PROTEIN; NITRIC OXIDE SYNTHASE TRAFFICKING INDUCER PROTEIN; PORIN; STRUCTURAL PROTEIN; TUBULIN; UNCLASSIFIED DRUG; ACTIN; NITRIC OXIDE; PROTEIN BINDING;

ANGIOGENESIS; ARTICLE; BLOOD VESSEL TONE; CELL MEMBRANE; ENDOTHELIUM CELL; ENZYME ACTIVITY; INTRACELLULAR MEMBRANE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; REGULATORY MECHANISM; THROMBOCYTE AGGREGATION; BIOSYNTHESIS; CHEMISTRY; HUMAN; METABOLISM;

ACTINS; APOLIPOPROTEIN A-I; CALMODULIN; DYNAMIN II; HSP90 HEAT-SHOCK PROTEINS; HUMANS; LIPOPROTEINS, HDL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PORINS; PROTEIN BINDING; TUBULIN;

EID: 84921451308     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/13816128113196660752     Document Type: Article

References (92)

1. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329: 2002-12.
2. Michel T, Feron O. Nitric oxide synthases: which, where, how, and why? J Clin Invest 1997; 100: 2146-52.
3. Su Y, Block ER. Pulmonary endothelium and nitric oxide. In: Voelkel N, Rounds S Eds. The pulmonary endothelium: Function in health and disease. John Wiley and Sons, Ltd 2009; pp. 89-104.
4. Su Y, Kondrikov D, Block ER. Cytoskeletal regulation of nitric oxide synthase. Cell Biochem Biophys 2005; 43: 439-50.
5. Su Y, Kondrikov D, Block ER. beta-actin: a regulator of NOS-3. Sci STKE 2007; 2007: e52-1-e52-3.
6. Fulton D, Gratton JP, Sessa WC. Post-translational control of endothelial nitric oxide synthase: why isn't calcium/calmodulin enough? J Pharmacol Exp Ther 2001; 299: 818-24.
7. Rodriguez-Crespo I, Ortiz de Montellano PR. Human endothelial nitric oxide synthase: expression in Escherichia coli, coexpression with calmodulin, and characterization. Arch Biochem Biophys 1996; 336: 151-6.
8. Venema RC, Sayegh HS, Kent JD, Harrison DG. Identification, characterization, and comparison of the calmodulin-binding domains of the endothelial and inducible nitric oxide synthases. J Biol Chem 1996; 271: 6435-40.
9. Matsubara M, Hayashi N, Titani K, Taniguchi H. Circular dichroism and 1H NMR studies on the structures of peptides derived from the calmodulin-binding domains of inducible and endothelial nitricoxide synthase in solution and in complex with calmodulin. Nascent alpha-helical structures are stabilized by calmodulin both in the presence and absence of Ca2+. J Biol Chem 1997; 272: 23050-6.
10. Hellermann GR, Solomonson LP. Calmodulin promotes dimerization of the oxygenase domain of human endothelial nitric-oxide synthase. J Biol Chem 1997; 272: 12030-4.
11. Michel JB, Feron O, Sacks D, Michel T. Reciprocal regulation of endothelial nitric-oxide synthase by Ca2+-calmodulin and caveolin. J Biol Chem 1997; 272: 15583-6.
12. Greif DM, Sacks DB, Michel T. Calmodulin phosphorylation and modulation of endothelial nitric oxide synthase catalysis. Proc Natl Acad Sci USA 2004; 101: 1165-70.
13. Shaul PW. Regulation of endothelial nitric oxide synthase: location, location, location. Annu Rev Physiol 2002; 64: 749-74.
14. Garcia-Cardena G, Fan R, Shah V, et al. Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature 1998; 392: 821-4.
15. Harris MB, Ju H, Venema VJ, Blackstone M, Venema RC. Role of heat shock protein 90 in bradykinin-stimulated endothelial nitric oxide release. Gen Pharmacol 2000; 35: 165-70.
16. Venema VJ, Marrero MB, Venema RC. Bradykinin-stimulated protein tyrosine phosphorylation promotes endothelial nitric oxide synthase translocation to the cytoskeleton. Biochem Biophys Res Commun 1996; 226: 703-10.
17. Fontana J, Fulton D, Chen Y, et al. Domain mapping studies reveal that the M domain of hsp90 serves as a molecular scaffold to regulate Akt-dependent phosphorylation of endothelial nitric oxide synthase and NO release. Circ Res 2002; 90: 866-73.
18. Xu H, Shi Y, Wang J, et al. A heat shock protein 90 binding domain in endothelial nitric-oxide synthase influences enzyme function. J Biol Chem 2007; 282: 37567-74.
19. Takahashi S, Mendelsohn ME. Calmodulin-dependent and-independent activation of endothelial nitric-oxide synthase by heat shock protein 90. J Biol Chem 2003; 278: 9339-44.
20. Sud N, Sharma S, Wiseman DA, et al. Nitric oxide and superoxide generation from endothelial NOS: modulation by HSP90. Am J Physiol Lung Cell Mol Physiol 2007; 293: L1444-L1453.
21. Takahashi S, Mendelsohn ME. Synergistic activation of endothelial nitric-oxide synthase (eNOS) by HSP90 and Akt: calciumindependent eNOS activation involves formation of an HSP90-Akt-CaM-bound eNOS complex. J Biol Chem 2003; 278: 30821-7.
22. Su Y, Block ER. Role of calpain in hypoxic inhibition of nitric oxide synthase activity in pulmonary endothelial cells. Am J Physiol Lung Cell Mol Physiol 2000; 278: L1204-L1212.
23. Fike CD, Pfister SL, Slaughter JC, et al. Protein complex formation with heat shock protein 90 in chronic hypoxia-induced pulmonary hypertension in newborn piglets. Am J Physiol Heart Circ Physiol 2010; 299: H1190-H1204.
24. Murata T, Sato K, Hori M, Ozaki H, Karaki H. Decreased endothelial nitric-oxide synthase (eNOS) activity resulting from abnormal interaction between eNOS and its regulatory proteins in hypoxiainduced pulmonary hypertension. J Biol Chem 2002; 277: 44085-92.
25. Stalker TJ, Skvarka CB, Scalia R. A novel role for calpains in the endothelial dysfunction of hyperglycemia. FASEB J 2003.
26. Valleggi S, Devaraj S, Dasu MR, Jialal I. C-reactive protein adversely alters the protein-protein interaction of the endothelial isoform of nitric oxide synthase. Clin Chem 2010; 56: 1345-8.
27. Brouet A, Sonveaux P, Dessy C, Moniotte S, Balligand JL, Feron O. Hsp90 and caveolin are key targets for the proangiogenic nitric oxide-mediated effects of statins. Circ Res 2001; 89: 866-73.
28. Polikandriotis JA, Mazzella LJ, Rupnow HL, Hart CM. Peroxisome proliferator-activated receptor gamma ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferatoractivated receptor gamma-dependent mechanisms. Arterioscler Thromb Vasc Biol 2005; 25: 1810-6.
29. Abbasi F, Chu JW, McLaughlin T, Lamendola C, Leary ET, Reaven GM. Effect of metformin treatment on multiple cardiovascular disease risk factors in patients with type 2 diabetes mellitus. Metabolism 2004; 53: 159-64.
30. Martinez-Ruiz A, Villanueva L, Gonzalez dO, et al. S-nitrosylation of Hsp90 promotes the inhibition of its ATPase and endothelial nitric oxide synthase regulatory activities. Proc Natl Acad Sci USA 2005; 102: 8525-30.
31. Fish KN, Schmid SL, Damke H. Evidence that dynamin-2 functions as a signal-transducing GTPase. J Cell Biol 2000; 150: 145-54.
32. Yao Q, Chen J, Cao H, et al. Caveolin-1 interacts directly with dynamin-2. J Mol Biol 2005; 348: 491-501.
33. Shajahan AN, Timblin BK, Sandoval R, Tiruppathi C, Malik AB, Minshall RD. Role of Src-induced dynamin-2 phosphorylation in caveolae-mediated endocytosis in endothelial cells. J Biol Chem 2004; 279: 20392-400.
34. Cao S, Yao J, McCabe TJ, et al. Direct interaction between endothelial nitric-oxide synthase and dynamin-2. Implications for nitricoxide synthase function. J Biol Chem 2001; 276: 14249-56.
35. Cao S, Yao J, Shah V. The proline-rich domain of dynamin-2 is responsible for dynamin-dependent in vitro potentiation of endothelial nitric-oxide synthase activity via selective effects on reductase domain function. J Biol Chem 2003; 278: 5894-901.
36. Sanchez FA, Kim DD, Duran RG, Meininger CJ, Duran WN. Internalization of eNOS via caveolae regulates PAF-induced inflammatory hyperpermeability to macromolecules. Am J Physiol Heart Circ Physiol 2008; 295: H1642-H1648.
37. Sanchez FA, Rana R, Kim DD, et al. Internalization of eNOS and NO delivery to subcellular targets determine agonist-induced hyperpermeability. Proc Natl Acad Sci USA 2009; 106: 6849-53.
38. Maniatis NA, Brovkovych V, Allen SE, et al. Novel mechanism of endothelial nitric oxide synthase activation mediated by caveolae internalization in endothelial cells. Circ Res 2006; 99: 870-7.
39. Icking A, Matt S, Opitz N, Wiesenthal A, Muller-Esterl W, Schilling K. NOSTRIN functions as a homotrimeric adaptor protein facilitating internalization of eNOS. J Cell Sci 2005; 118: 5059-69.
40. Skidgel RA. Proliferation of regulatory mechanisms for eNOS: an emerging role for the cytoskeleton. Am J Physiol Lung Cell Mol Physiol 2002; 282: L1179-L1182.
41. Su Y, Zharikov SI, Block ER. Microtubule-active agents modify nitric oxide production in pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol 2002; 282: L1183-L1189.
42. Su Y, Edwards-Bennett S, Bubb MR, Block ER. Regulation of endothelial nitric oxide synthase by the actin cytoskeleton. Am J Physiol Cell Physiol 2003; 284: C1542-C1549.
43. Lee NP, Yan CC. Regulation of Sertoli cell tight junction dynamics in the rat testis via the nitric oxide synthase/soluble guanylate cy-clase/3',5'-cyclic guanosine monophosphate/protein kinase G signaling pathway: an in vitro study. Endocrinology 2003; 144: 3114-29.
44. Kondrikov D, Han HR, Block ER, Su Y. Growth and density-dependent regulation of NO synthase by the actin cytoskeleton in pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol 2006; 290: L41-L50.
45. Kondrikov D, Fonseca FV, Elms S, et al. Beta-actin association with endothelial nitric-oxide synthase modulates nitric oxide and superoxide generation from the enzyme. J Biol Chem 2010; 285: 4319-27.
46. Kanzaki M, Pessin JE. Caveolin-associated filamentous actin (Cavactin) defines a novel F-actin structure in adipocytes. J Biol Chem 2002; 277: 25867-9.
47. Nishida E, Koyasu S, Sakai H, Yahara I. Calmodulin-regulated binding of the 90-kDa heat shock protein to actin filaments. J Biol Chem 1986; 261: 16033-6.
48. Koyasu S, Nishida E, Kadowaki T, et al. Two mammalian heat shock proteins, HSP90 and HSP100, are actin-binding proteins. Proc Natl Acad Sci USA 1986; 83: 8054-8.
49. Czar MJ, Welsh MJ, Pratt WB. Immunofluorescence localization of the 90-kDa heat-shock protein to cytoskeleton. Eur J Cell Biol 1996; 70: 322-30.
50. Orth JD, McNiven MA. Dynamin at the actin-membrane interface. Curr Opin Cell Biol 2003; 15: 31-9.
51. Zharikov SI, Block ER. Association of L-arginine transporters with fodrin: implications for hypoxic inhibition of arginine uptake. Am J Physiol Lung Cell Mol Physiol 2000; 278: L111-L117.
52. Zimmermann K, Opitz N, Dedio J, Renne C, Muller-Esterl W, Oess S. NOSTRIN: a protein modulating nitric oxide release and subcellular distribution of endothelial nitric oxide synthase. Proc Natl Acad Sci USA 2002; 99: 17167-72.
53. Ji Y, Ferracci G, Warley A, et al. beta-Actin regulates platelet nitric oxide synthase 3 activity through interaction with heat shock protein 90. Proc Natl Acad Sci USA 2007; 104: 8839-44.
54. Mi Q, Chen N, Shaifta Y, et al. Activation of endothelial nitric oxide synthase is dependent on its interaction with globular actin in human umbilical vein endothelial cells. J Mol Cell Cardiol 2011; 51: 419-27.
55. Dedio J, Konig P, Wohlfart P, Schroeder C, Kummer W, Muller-Esterl W. NOSIP, a novel modulator of endothelial nitric oxide synthase activity. FASEB J 2001; 15: 79-89.
56. Whitney JA, German Z, Sherman TS, Yuhanna IS, Shaul PW. Cell growth modulates nitric oxide synthase expression in fetal pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol 2000; 278: L131-L138.
57. Kondrikov D, Elms S, Fulton D, Su Y. eNOS-beta-actin interaction contributes to increased peroxynitrite formation during hyperoxia in pulmonary artery endothelial cells and mouse lungs. J Biol Chem 2010; 285: 35479-87.
58. Sun J, Liao JK. Functional interaction of endothelial nitric oxide synthase with a voltage-dependent anion channel. Proc Natl Acad Sci USA 2002; 99: 13108-13.
59. Alvira CM, Umesh A, Husted C, et al. Voltage-dependent anion channel-2 interaction with nitric oxide synthase enhances pulmonary artery endothelial cell nitric oxide production. Am J Respir Cell Mol Biol 2012; 47: 669-78.
60. Drew BG, Fidge NH, Gallon-Beaumier G, Kemp BE, Kingwell BA. High-density lipoprotein and apolipoprotein AI increase endothelial NO synthase activity by protein association and multisite phosphorylation. Proc Natl Acad Sci USA 2004; 101: 6999-7004.
61. Lisanti MP, Scherer PE, Vidugiriene J, et al. Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease. J Cell Biol 1994; 126: 111-26.
62. Rothberg KG, Heuser JE, Donzell WC, Ying YS, Glenney JR, Anderson RG. Caveolin, a protein component of caveolae membrane coats. Cell 1992; 68: 673-82.
63. Feron O, Saldana F, Michel JB, Michel T. The endothelial nitricoxide synthase-caveolin regulatory cycle. J Biol Chem 1998; 273: 3125-8.
64. Garcia-Cardena G, Fan R, Stern DF, Liu J, Sessa WC. Endothelial nitric oxide synthase is regulated by tyrosine phosphorylation and interacts with caveolin-1. J Biol Chem 1996; 271: 27237-40.
65. Ju H, Zou R, Venema VJ, Venema RC. Direct interaction of endothelial nitric-oxide synthase and caveolin-1 inhibits synthase activity. J Biol Chem 1997; 272: 18522-5.
66. Feron O, Belhassen L, Kobzik L, Smith TW, Kelly RA, Michel T. Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. J Biol Chem 1996; 271: 22810-4.
67. Garcia-Cardena G, Martasek P, Masters BS, et al. Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the nos caveolin binding domain in vivo. J Biol Chem 1997; 272: 25437-40.
68. Michel JB, Feron O, Sase K, Prabhakar P, Michel T. Caveolin versus calmodulin. Counterbalancing allosteric modulators of endothelial nitric oxide synthase. J Biol Chem 1997; 272: 25907-12.
69. Marrero MB, Venema VJ, Ju H, et al. Endothelial nitric oxide synthase interactions with G-protein-coupled receptors. Biochem J 1999; 343 Pt 2: 335-40.
70. Ju H, Venema VJ, Marrero MB, Venema RC. Inhibitory interactions of the bradykinin B2 receptor with endothelial nitric-oxide synthase. J Biol Chem 1998; 273: 24025-9.
71. Schleicher M, Brundin F, Gross S, Muller-Esterl W, Oess S. Cell cycle-regulated inactivation of endothelial NO synthase through NOSIP-dependent targeting to the cytoskeleton. Mol Cell Biol 2005; 25: 8251-8.
72. Icking A, Schilling K, Wiesenthal A, Opitz N, Muller-Esterl W. FCH/Cdc15 domain determines distinct subcellular localization of NOSTRIN. FEBS Lett 2006; 580: 223-8.
73. Schilling K, Opitz N, Wiesenthal A, et al. Translocation of endothelial nitric-oxide synthase involves a ternary complex with caveolin-1 and NOSTRIN. Mol Biol Cell 2006; 17: 3870-80.
74. Mookerjee RP, Wiesenthal A, Icking A, et al. Increased gene and protein expression of the novel eNOS regulatory protein NOSTRIN and a variant in alcoholic hepatitis. Gastroenterology 2007; 132: 2533-41.
75. Xiang W, Chen H, Guo Y, Shen H. Expression of endothelial nitric oxide synthase traffic inducer in the placenta of pregnancy induced hypertension. J Huazhong Univ Sci Technolog Med Sci 2006; 26: 356-8.
76. Deves R, Boyd CA. Transporters for cationic amino acids in animal cells: discovery, structure, and function. Physiol Rev 1998; 78: 487-545.
77. Hallemeesch MM, Lamers WH, Deutz NE. Reduced arginine availability and nitric oxide production. Clin Nutr 2002; 21: 273-9.
78. Zharikov SI, Block ER. Characterization of L-arginine uptake by plasma membrane vesicles isolated from cultured pulmonary artery endothelial cells. Biochim Biophys Acta 1998; 1369: 173-83.
79. Closs EI, Boissel JP, Habermeier A, Rotmann A. Structure and function of cationic amino acid transporters (CATs). J Membr Biol 2006; 213: 67-77.
80. Hammermann R, Brunn G, Racke K. Analysis of the genomic organization of the human cationic amino acid transporters CAT-1, CAT-2 and CAT-4. Amino Acids 2001; 21: 211-9.
81. Aisaka K, Gross SS, Griffith OW, Levi R. L-arginine availability determines the duration of acetylcholine-induced systemic vasodilation in vivo. Biochem Biophys Res Commun 1989; 163: 710-7.
82. Eddahibi S, Adnot S, Carville C, Blouquit Y, Raffestin B. Larginine restores endothelium-dependent relaxation in pulmonary circulation of chronically hypoxic rats. Am J Physiol 1992; 263: L194-L200.
83. Closs EI, Scheld JS, Sharafi M, Forstermann U. Substrate supply for nitric-oxide synthase in macrophages and endothelial cells: role of cationic amino acid transporters. Mol Pharmacol 2000; 57: 68-74.
84. Simon A, Plies L, Habermeier A, Martine U, Reining M, Closs EI. Role of neutral amino acid transport and protein breakdown for substrate supply of nitric oxide synthase in human endothelial cells. Circ Res 2003; 93: 813-20.
85. McDonald KK, Zharikov S, Block ER, Kilberg MS. A caveolar complex between the cationic amino acid transporter 1 and endothelial nitric-oxide synthase may explain the "arginine paradox". J Biol Chem 1997; 272: 31213-6.
86. Zharikov SI, Krotova KY, Belayev L, Block ER. Pertussis toxin activates L-arginine uptake in pulmonary endothelial cells through downregulation of PKC-alpha activity. Am J Physiol Lung Cell Mol Physiol 2004; 286: L974-L983.
87. Wu G, Morris SM, Jr. Arginine metabolism: nitric oxide and beyond. Biochem J 1998; 336 (Pt 1): 1-17.
88. Su Y, Block ER. Hypoxia inhibits L-arginine synthesis from Lcitrulline in porcine pulmonary artery endothelial cells. Am J Physiol 1995; 269: L581-L587.
89. Flam BR, Hartmann PJ, Harrell-Booth M, Solomonson LP, Eichler DC. Caveolar localization of arginine regeneration enzymes, argininosuccinate synthase, and lyase, with endothelial nitric oxide synthase. Nitric Oxide 2001; 5: 187-97.
90. Flam BR, Eichler DC, Solomonson LP. Endothelial nitric oxide production is tightly coupled to the citrulline-NO cycle. Nitric Oxide 2007.
91. Poulos TL. Soluble guanylate cyclase. Curr Opin Struct Biol 2006; 16: 736-43.
92. Venema RC, Venema VJ, Ju H, et al. Novel complexes of guanylate cyclase with heat shock protein 90 and nitric oxide synthase. Am J Physiol Heart Circ Physiol 2003; 285: H669-H678.